Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancer Research|April 9, 2009
K858, a novel inhibitor of mitotic kinesin Eg5 and antitumor agent, induces cell death in cancer cellsRyuichiro Nakai, Shin-ichi Iida, Takeshi Takahashi, et al.Cancer Research|July 23, 2003
A novel telomerase template antagonist (GRN163) as a potential anticancer agentAkira Asai, Yuko Oshima, Yoshihiro Yamamoto, et al.Blood|June 23, 2009
KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocationYukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2014
Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphomaMichinori Ogura, Takashi Ishida, Kiyohiko Hatake, et al.Molecular Cancer Therapeutics|August 26, 2015
A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor ModelsXiang S Ye, Li Fan, Robert D Van Horn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II studyTakashi Ishida, Tatsuro Joh, Naokuni Uike, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphomaKazuhito Yamamoto, Atae Utsunomiya, Kensei Tobinai, et al.British Journal of Haematology|March 4, 2015
Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II studyTakashi Ishida, Tatsuro Jo, Shigeki Takemoto, et al.Pageof 5